# OnCo record foenix-cca2 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/foenix-cca2/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "foenix-cca2", "NCT02052778" ;
  schema:name "FOENIX-CCA2"@en ;
  schema:description "Futibatinib produced responses in over 40% of patients whose bile duct cancer carried an FGFR2 fusion."@en ;
  schema:url <https://onco.cc/trials/foenix-cca2/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02052778>, <https://www.nejm.org/doi/full/10.1056/NEJMoa2206834> ;
  onco:status "positive" ;
  onco:phase "1/2" ;
  schema:startDate "2014-07-21" ;
  onco:cancers <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/intrahepatic-cholangiocarcinoma/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/fgfr2/> ;
  onco:drugs <https://onco.cc/drugs/futibatinib/> ;
  onco:companies <https://onco.cc/companies/taiho/> ;
  onco:people <https://onco.cc/people/lipika-goyal/> .